ArticleOrphanet journal of rare diseases2022

Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment.

Amanda Mortensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.